Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Cell Therapy for Kidney Cancer
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial is testing a new cancer therapy that takes white blood cells from a person, grows them in a lab, and changes them with a virus to attack tumor cells. The objective is to see if gene transfer is safe and causes tumors to shrink. Eligible participants are people at least 18 years old with certain kidney cancer. The trial involves several hospital stays and clinic visits over the course of 2 years, with follow-up checks for up to 15 years.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.